Efficacy and safety of tigecycline for Mycobacterium abscessus disease

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman et al. · Thorax · 2015 · 470 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +13

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman et al. · Thorax · 2015 · 460 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

G. Muralidharan, Marlynne Micalizzi, John Speth et al. · Antimicrobial Agents and Chemotherapy · 2004 · 336 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria

Richard J. Wallace, Barbara A. Brown‐Elliott, Christopher J. Crist et al. · Antimicrobial Agents and Chemotherapy · 2002 · 227 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections

Richard J. Wallace, Gary Dukart, Barbara A. Brown‐Elliott et al. · Journal of Antimicrobial Chemotherapy · 2014 · 184 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +12